GleamWall
中文EN

SRTS Sensus Healthcare, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1494891 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-53.3%
TTM net income YoY-433.4%
TTM EPS YoY-438.9%
Revenue 3-yr CAGR-12.7%
Net income 3-yr CAGR—

Margins

Gross margin41.8%
Operating margin-74.0%
Net margin-96.5%
FCF margin-69.4%
EBITDA margin-71.9%

Returns

ROE-37.0%
ROA-32.4%
ROIC (approx.)-39.5%
Asset turnover0.34x

Leverage & solvency

Liabilities / assets12.6%
Debt / equity0.00x
Current ratio6.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.71x
Accruals ratio-9.5%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$27.48M$41.81M
Cost of revenue$15.62M$17.38M
Gross profit$11.87M$24.43M
R&D expense$7.78M$4.22M
SG&A expense$7.87M$7.15M
Operating income-$10.31M$8.09M
Interest expense—-$932,000
Pretax income-$9.62M$9.02M
Income tax-$1.91M$2.38M
Net income-$7.72M$6.65M
EBITDA-$9.91M$8.29M
EPS (basic)-0.470.41
EPS (diluted)-0.470.41
Weighted avg. shares (diluted)16.33M16.36M
Banking
Net interest income$683,000$932,000
Balance sheet
Cash & equivalents$22.08M$22.06M
Receivables$6.04M$19.73M
Inventory$14.56M$10.10M
Current assets$45.89M$56.74M
PP&E, net$1.98M$2.00M
Total assets$53.04M$62.16M
Current liabilities$4.72M$5.88M
Total liabilities$4.94M$6.34M
Shareholders' equity$48.10M$55.83M
Shares outstanding16.46M16.50M
Cash flow statement
Operating cash flow$528,000-$831,000
Capital expenditure$196,000$276,000
Free cash flow$332,000-$1.11M
Investing cash flow-$196,000-$276,000
Financing cash flow-$305,000$15,000
Depreciation & amortization$400,000$200,000
Stock-based compensation$295,000$323,000
Share buybacks$300,000—

Free plan shows the latest 2 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.